United Kingdom
Eulysis UK Ltd, an acquired company in 2016, stands out for its innovative strides in the biotechnology, medical devices, and pharmaceutical industries. Founded in 2010 and headquartered in the United Kingdom, Eulysis has developed the pioneering Single Vial System that doubles medication delivery efficiency at reduced costs. This technology streamlines the traditional method of using two containers for pharmaceuticals and vaccines, significantly mitigating risks like contamination, waste, and accessibility, while enhancing the cold supply chain.
Eulysis's disruptive technology appeals to investors seeking impactful healthcare innovations with a potentially transformative effect on global medicine distribution. By simplifying packaging and reducing costs, it addresses critical industry inefficiencies and expands access to essential medicines worldwide.
